Leaseir MHR Xcell (console) (MHR-100b); Handpiece: Dual (810-b and Blend-b); Handpiece: Quad (810-b and Blend-b)— 510(k) K253251

Name: FDA 510(k) clearance K253251
Creator: U.S. Food and Drug Administration
Published: 2026-05-04

Substantially Equivalent

Leaseir Technologies, Slu

FDA 510(k) clearance K253251 for Leaseir MHR Xcell (console) (MHR-100b); Handpiece: Dual (810-b and Blend-b); Handpiece: Quad (810-b and Blend-b), Substantially Equivalent on 2026-05-04. Applicant: Leaseir Technologies, Slu. Device class: 2.

Clearance details

Applicant: Leaseir Technologies, Slu
Product code: Code GEX
Device class: Class 2
Regulation: 21 CFR 878.4810
Advisory panel: General, Plastic Surgery
Date received: 2025-09-29
Decision date: 2026-05-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Gijon, ES

Download summary PDF View on FDA.gov ↗

Recent devices under product code GEX

view all

K241973 — SmartIPL_NI System2026-09-19
K252723 — Dynamis Pro Family2026-09-19
K261047 — Dental Diode Laser Device (Laser-Pen)2026-09-18
K261673 — LED Therapy Device (QLXY-01)2026-09-17
K261817 — Diode Laser Therapy System (PZ-BDT67-01, PZ-BDT67-02)2026-09-17

More clearances from Leaseir Technologies, Slu

view all

K214049 — Leaseir MHR Xcell2022-06-02

Adverse events under product code GEX

product code GEX

Death: 33
Injury: 3,045
Malfunction: 12,903
Other: 25
Total: 16,006

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.